Statistics In the Pharmaceutical Industry
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
Januar 2023, ca. 496 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
Januar 2023, ca. 496 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Weitere Titel der Reihe: Chapman & Hall/CRC Biostatistics Series
Alle anzeigenMedical Statistics for Cancer Studies
Taylor and Francis, 2024
978-1-032-28587-0
79.00 CHF
sofort lieferbar
Statistical Analytics for Health Data Science with SAS and R
Taylor and Francis, 2023
978-1-03-232562-0
ca. 140.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Methods in Health Economics
Taylor and Francis, 2023
978-1-03-247753-4
ca. 80.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Data Science, AI, and Machine Learning in Drug Development
Taylor and Francis, 2022
978-0-367-70807-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2020
978-0-367-73187-8
ca. 86.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Artificial Intelligence for Drug Development, Precision Medicine, and Healthcare
Taylor and Francis, 2020
978-0-367-36292-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2019
978-1-138-73173-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
An Applied Approach Using SAS & STATA
Taylor and Francis, 2015
978-1-4665-0547-6
ca. 146.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Benefit-Risk Assessment in Pharmaceutical Research and Development
Taylor and Francis, 2013
978-1-4398-6794-5
ca. 156.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Weitere Titel zum Thema
Multi-Criteria Decision-Making
Principles, Methods and Programs
Taylor and Francis, 2026
978-1-032-85363-5
ca. 160.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Biopolymer Based Nano Drug Delivery for Cancer Wound Healing
Elsevier, 2026
978-0-443-34673-6
ca. 229.00 CHF
erscheint im Oktober
Environmental Sustainability and Green Technology in Pharmaceutical Research
Current Issues and Future Directions
Taylor and Francis, 2026
978-1-041-07432-8
ca. 249.00 CHF
erscheint im Juli
AI Powered Drug delivery to Neuro and Cardiovascular Systems
Perspectives and Future Challenges
Elsevier, 2026
978-0-443-40441-2
ca. 225.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Basics of Pharmaceutical Manufacturing and Quality Operations
A Comprehensive Guide
Taylor and Francis, 2026
978-1-032-43246-5
ca. 89.00 CHF
erscheint im Mai
Advances in Tablet Manufacturing Technologies
Elsevier, 2026
978-0-443-36751-9
ca. 255.00 CHF
erscheint im Mai
Artificial Intelligence in Precision Drug Design, Volume 2
Advanced Applications
Elsevier, 2026
978-0-443-44430-2
ca. 255.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Economics of the Pharmaceutical and Medical Device Industry
Supply Chain, Trade and Innovation
Taylor and Francis, 2026
978-1-032-58265-8
ca. 75.00 CHF
erscheint im Mai
Cellular Therapies for Cancer Treatment
Advancements in Drug Delivery Strategies
Elsevier, 2026
978-0-443-34141-0
ca. 229.00 CHF
erscheint im Oktober
Lipid Nanoparticles-Based mRNA Delivery System
Elsevier, 2026
978-0-443-45006-8
ca. 255.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Prescriptions for Quant Traders Using R
Videos & Scripts
Taylor and Francis, 2026
978-1-032-97226-8
ca. 309.00 CHF
lieferbar in ca. 10-20 Arbeitstagen